熱門資訊> 正文
Ekso Bionics私募股权定价为590万美元
2026-01-21 22:06
- Ekso Bionics (EKSO) on Wednesday said it entered into securities purchase agreements on Jan. 20, 2026, with institutional and accredited investors for a private placement of 5,852 shares of Series B preferred stock and warrants to buy up to 0.36M common shares.
- Each preferred share has a stated value of $1,000 and may be converted at any time into common stock at $8.22 per share, representing 0.71M shares in total.
- The company said the warrants will become exercisable six months after closing at $8.22 per share and will expire five years thereafter.
- The offering is expected to close on or about Jan. 22, 2026, subject to customary closing conditions.
- Gross proceeds from the private placement are expected to be about $5.9M, with net proceeds to be used for working capital and general corporate purposes.
- Shares -7.22%.
More on Ekso Bionics Holdings
- Applied Digital to spin out cloud business, to combine with EKSO to launch Chronoscale
- Seeking Alpha’s Quant Rating on Ekso Bionics Holdings
- Historical earnings data for Ekso Bionics Holdings
- Financial information for Ekso Bionics Holdings
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
